• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体生物发生障碍中的迟发性白质病

Late onset white matter disease in peroxisome biogenesis disorder.

作者信息

Barth P G, Gootjes J, Bode H, Vreken P, Majoie C B, Wanders R J

机构信息

Department of Pediatrics, Emma Children's Hospital/AMC, Amsterdam, The Netherlands.

出版信息

Neurology. 2001 Dec 11;57(11):1949-55. doi: 10.1212/wnl.57.11.1949.

DOI:10.1212/wnl.57.11.1949
PMID:11769739
Abstract

OBJECTIVE

To report late onset cerebral white matter disease as a distinctive phenotype in peroxisome biogenesis disorder (PBD).

BACKGROUND

There is phenotypic and genetic overlap among the PBD known as Zellweger syndrome (ZS), infantile Refsum disease (IRD), and neonatal adrenoleukodystrophy (NALD). Distinctive external features are variable among these three disorders, and neurologic deficit has its onset at birth or in infancy. In a structured follow-up cohort of 25 patients with PBD, not including ZS, three patients had an unusual pattern of cerebral white matter disease with onset past the age of 1, not conforming to any of the classic PBD phenotypes.

METHODS

Clinical phenotyping and follow-up, peroxisomal biochemical determinations in body fluids and fibroblasts, identification of affected PEX gene by genetic complementation in fibroblasts, and MRI studies.

RESULTS

Two unrelated patients with PBD without distinctive external features had normal neurodevelopmental milestones during their first year, followed by rapid deterioration including severe hypotonic pareses, seizures, retinopathy, and deafness. A third patient initially diagnosed with IRD developed cerebral white matter degeneration in the third year of life, complicating the original diagnosis. MRI in all three patients showed cerebral demyelination with sparing of subcortical fibers and pronounced central cerebellar demyelination.

CONCLUSIONS

Late-onset cerebral white matter disease may occur in PBD, either following IRD or following normal early development and in the absence of distinctive external features. Peroxisome biogenesis disorder should be included in the differential diagnosis of post-infantile onset of cerebral white matter disease

摘要

目的

报告迟发性脑白质病作为过氧化物酶体生物发生障碍(PBD)的一种独特表型。

背景

被称为泽尔韦格综合征(ZS)、婴儿型雷夫叙姆病(IRD)和新生儿肾上腺脑白质营养不良(NALD)的PBD之间存在表型和基因重叠。这三种疾病的独特外部特征各不相同,且神经功能缺损在出生时或婴儿期就已出现。在一个由25名PBD患者(不包括ZS)组成的结构化随访队列中,有三名患者出现了不寻常的脑白质病模式,发病年龄超过1岁,不符合任何经典的PBD表型。

方法

临床表型分析和随访、体液和成纤维细胞中的过氧化物酶体生化测定、通过成纤维细胞中的基因互补鉴定受影响的PEX基因以及MRI研究。

结果

两名无独特外部特征的PBD无关患者在第一年神经发育里程碑正常,随后迅速恶化,包括严重的低张力性轻瘫、癫痫、视网膜病变和耳聋。第三名最初被诊断为IRD的患者在生命的第三年出现脑白质变性,使原诊断复杂化。所有三名患者的MRI均显示脑脱髓鞘,皮质下纤维未受累,小脑中央明显脱髓鞘。

结论

迟发性脑白质病可能发生在PBD中,可继发于IRD之后,或在早期发育正常且无独特外部特征的情况下出现。过氧化物酶体生物发生障碍应纳入婴儿期后发生的脑白质病的鉴别诊断中。

相似文献

1
Late onset white matter disease in peroxisome biogenesis disorder.过氧化物酶体生物发生障碍中的迟发性白质病
Neurology. 2001 Dec 11;57(11):1949-55. doi: 10.1212/wnl.57.11.1949.
2
Pharmacological induction of peroxisomes in peroxisome biogenesis disorders.过氧化物酶体生物发生障碍中过氧化物酶体的药理学诱导
Ann Neurol. 2000 Mar;47(3):286-96.
3
Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives.过氧化物酶体生物发生障碍:生物学、临床及病理生理学视角
Dev Disabil Res Rev. 2013;17(3):187-96. doi: 10.1002/ddrr.1113.
4
Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.由PEX1基因突变导致的过氧化物酶体生物发生障碍:表型与PEX1蛋白水平
Am J Hum Genet. 2001 Jul;69(1):35-48. doi: 10.1086/321265. Epub 2001 Jun 1.
5
Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction.PEX1缺陷互补组1过氧化物酶体生物发生障碍中的表型-基因型关系由Pex1p-Pex6p相互作用定义。
Biochem J. 2001 Jul 15;357(Pt 2):417-26. doi: 10.1042/0264-6021:3570417.
6
Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders.PEX基因产物缺陷与过氧化物酶体生物发生障碍中的蛋白质导入、生化异常及表型异质性相关。
J Med Genet. 1999 Oct;36(10):779-81. doi: 10.1136/jmg.36.10.779.
7
Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders.人类PEX1在过氧化物酶体生物发生障碍的互补组1中发生突变。
Nat Genet. 1997 Dec;17(4):449-52. doi: 10.1038/ng1297-449.
8
Biochemical markers predicting survival in peroxisome biogenesis disorders.预测过氧化物酶体生物发生障碍患者生存情况的生化标志物。
Neurology. 2002 Dec 10;59(11):1746-9. doi: 10.1212/01.wnl.0000036609.14203.70.
9
Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients.存活期延长的过氧化物酶体生物发生障碍:31例患者队列中的表型表现
Am J Med Genet A. 2004 May 1;126A(4):333-8. doi: 10.1002/ajmg.a.20664.
10
[Molecular analysis of peroxisomal disorders].[过氧化物酶体疾病的分子分析]
No To Hattatsu. 1998 Mar;30(2):128-33.

引用本文的文献

1
Identification of novel compound heterozygous variants in the PEX10 gene in a Han-Chinese family with PEX10-related peroxisome biogenesis disorders.在一个患有PEX10相关过氧化物酶体生物发生障碍的汉族家庭中鉴定PEX10基因新的复合杂合变异体。
PLoS One. 2025 Apr 23;20(4):e0322137. doi: 10.1371/journal.pone.0322137. eCollection 2025.
2
Identification of a Novel Non-Canonical Splice-Site Variant in .鉴定出一个位于……的新型非典型剪接位点变异体 。 (你提供的原文不完整,缺少具体位置等关键信息,这是根据现有内容尽量完整翻译的结果)
J Clin Med. 2023 Jan 6;12(2):473. doi: 10.3390/jcm12020473.
3
The Key Role of Peroxisomes in Follicular Growth, Oocyte Maturation, Ovulation, and Steroid Biosynthesis.
过氧化物酶体在卵泡生长、卵母细胞成熟、排卵和类固醇生物合成中的关键作用。
Oxid Med Cell Longev. 2022 Feb 3;2022:7982344. doi: 10.1155/2022/7982344. eCollection 2022.
4
Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.由一种新型PEX6突变导致的轻度脑肝肾综合征:临床表型与变异致病性的计算机模拟预测之间的相关性
J Appl Genet. 2017 Nov;58(4):475-480. doi: 10.1007/s13353-017-0414-5. Epub 2017 Oct 18.
5
Zellweger spectrum disorders: clinical overview and management approach.泽尔韦格谱系障碍:临床概述与管理方法。
Orphanet J Rare Dis. 2015 Dec 1;10:151. doi: 10.1186/s13023-015-0368-9.
6
X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.X 连锁肾上腺脑白质营养不良(X-ALD):临床表现及诊断、随访和管理指南。
Orphanet J Rare Dis. 2012 Aug 13;7:51. doi: 10.1186/1750-1172-7-51.
7
Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients.脑 MRI 作为泽尔韦格综合征患者有价值的诊断工具。
J Inherit Metab Dis. 2008 Apr;31(2):270-80. doi: 10.1007/s10545-008-0856-3. Epub 2008 Apr 14.
8
Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease.用于诊断脑白质营养不良及其他伴有白质病变疾病的工具。
Curr Neurol Neurosci Rep. 2005 Mar;5(2):110-8. doi: 10.1007/s11910-005-0008-1.
9
Peroxisomal biogenesis disorder: comparison of conventional MR imaging with diffusion-weighted and diffusion-tensor imaging findings.过氧化物酶体生物发生障碍:传统磁共振成像与扩散加权成像及扩散张量成像结果的比较
AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1022-7.